Isolation and characterization of Vancomycin resistant Staphylococcus aureus (VRSA) from Intensive Care Units (ICU) of different hospitals in Lahore, Pakistan
Abstract
Background: Nosocomial infections present a major threat because of the increased prevalence of clinical cases appearing among both developed as well as developing countries thus resulting in an alarming condition. This descriptive study was designed to determine the prevalence of hospital acquired vancomycin resistant Staphylococcus aureus (VRSA) in intensive care units (ICU) of different hospitals of Lahore.
Methods: Sixty three swab samples were collected from different local hospitals in Lahore. The study was conducted at the Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore from 2013 to 2014. Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA) and VRSA were isolated and confirmed using Clinical & Laboratory Standard Institute (CLSI), 2015 guidelines. vanA gene was amplified to determine the molecular basis of resistance of all VRSA isolates by using strain of S. aureus (ATCC 29213) as a gold standard.
Results: Prevalence of VRSA is comparatively low in the hospital settings of Lahore than MRSA. Out of sixty three S. aureus, four (6%) isolates were VRSA positive, and eight isolates (17%) showed intermediate resistance. The absence of vanA gene in VRSA showed that mechanism of resistance is other than vanA gene transfer.
Conclusions: Presence of VRSA in hospital settings is alarming for health care workers, patients and researchers and it also highlights the importance of alternative medicines to cure infections.
Keywords: Vancomycin, Methicillin resistance, Staphylococcus aureus, Plasmids
Full Text:
PDFReferences
McMaster J, Booth MG, Smith A, Hamilton K. Meticillin-resistant Staphylococcus aureus in the intensive care unit: its effect on outcome and risk factors for acquisition. Journal of Hospital Infection, (2015); 90(4): 327-332.
Khokhlova OE, Hung WC, Wan TW, Iwao Y, Takano T, et al. Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution. Plos One, (2015); 10(6).
Rivera AM, Boucher HW. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant Pneumococci, and vancomycin-resistant Enterococci; 2011. Elsevier. pp. 1230-1243.
Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Clinical microbiology reviews, (2002); 15(3): 430-438.
Tenover FC. Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm? Clinical Infectious Diseases, (2008); 46(5): 675-677.
Denys GA, Relich RF. Antibiotic Resistance in Nosocomial Respiratory Infections. Clinics in Laboratory Medicine, (2014); 34(2): 257-270.
Limbago BM, Kallen AJ, Zhu W, Eggers P, McDougal LK, et al. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. Journal of clinical microbiology, (2014); 52(3): 998-1002.
Daum RS, Gupta S, Sabbagh R, Milewski WM. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. The Journal of Infectious Diseases, (1992); 166(5): 1066-1072.
Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrobial Agents and Chemotherapy, (2000); 44(9): 2276-2285.
Billot-Klein D, Gutmann L, Bryant D, Bell D, Van Heijenoort J, et al. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. Journal of Bacteriology, (1996); 178(15): 4696-4703.
Clewell DB, Francia MV, Flannagan SE, An FY. Enterococcal plasmid transfer: sex pheromones, transfer origins, relaxases, and the Staphylococcus aureus issue. Plasmid, (2002); 48(3): 193-201.
Finks J, Wells E, Dyke TL, Husain N, Plizga L, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerging Infectious Diseases, (2009); 15(6): 943-945.
De Vriese AS, Vandecasteele SJ. Vancomycin: the tale of the vanquisher and the pyrrhic victory. Peritoneal Dialysis International, (2014); 34(2): 154-161.
Lee WG, Huh JY, Cho SR, Lim YA. Reduction in glycopeptide resistance in vancomycin-resistant Enterococci as a result of vanA cluster rearrangements. Antimicrobial Agents and Chemotherapy, (2004); 48(4): 1379-1381.
Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clinical Microbiology Reviews, (2007); 20(1): 79-114.
Arthur M, Quintiliani R, Jr. Regulation of VanA- and VanB-type glycopeptide resistance in Enterococci. Antimicrobial Agents and Chemotherapy, (2001); 45(2): 375-381.
Cappuccino JG, Sherman N. Basic Laboratory Techniques for Isolation, Cultivation, and Cultural Characterization of Microorganisms. Microbiology: A Laboratory Manual, (2013); 11: 1-560 Pearson Education Limited, United Kingdom.
Institute CaLS (2015) CLSI 2015: Antimicrobial Susceptibility Testing. USA: Wayne, Pennsylvania.
Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Journal of Antimicrobial Chemotherapy, (2006); 57(4): 589-608.
Fernandes CJ, Fernandes LA, Collignon P. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, (2005); 55(4): 506-510.
Soriano A, Marco F, Martínez JA, Pisos E, Almela M, et al. Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Clinical Infectious Diseases, (2008); 46(2): 193-200.
Ausubel F, Brent R. Kingston, RE, Moore, DD, Seidman, JG, Smith, JA and Struhl, K.(eds) 1987. Current Protocols in Molecular Biology, (1987); 18.5.
Bimboim H, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research, (1979); 7(6): 1513-1523.
Green MR, Hughes H, Sambrook J, MacCallum P. "Molecular cloning: a laboratory manual." Molecular Cloning: a Laboratory Manual. (2012). 1890-1890. CSHL Press, United States.
Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in Enterococci and to study gene organization in VanA isolates. Antimicrobial Agents and Chemotherapy, (1995); 39(8): 1772-1778.
Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrobial Agents and Chemotherapy, (1995); 39(8): 1772-1778.
Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging infectious diseases, (2001); 7(2): 327.
Carbon C. MRSA and MRSE: is there an answer? Clinical Microbiology and Infection, (2000); 617-22.
Onanuga A, Temedie TC. Multidrug-resistant intestinal Staphylococcus aureus among self-medicated healthy adults in Amassoma, South-South, Nigeria. Journal of Health, Population, and Nutrition, (2011); 29(5): 446.
Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infectious Diseases, (2006); 6(1): 156.
Maki H, McCallum N, Bischoff M, Wada A, Berger-Bächi B. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, (2004); 48(6): 1953-1959.
Brady RA, Leid JG, Kofonow J, Costerton JW, Shirtliff ME. Immunoglobulins to surface-associated biofilm immunogens provide a novel means of visualization of methicillin-resistant Staphylococcus aureus biofilms. Applied and Environmental Microbiology, (2007); 73(20): 6612-6619.
Lam MW, Young CJ, Brain RA, Johnson DJ, Hanson MA, et al. Aquatic persistence of eight pharmaceuticals in a microcosm study. Environmental Toxicology and Chemistry, (2004); 23(6): 1431-1440.
Karabey S, Ay P, Derbentli S, Nakipoglu Y, Esen F. Handwashing frequencies in an intensive care unit. Journal of Hospital Infection, (2002); 50(1): 36-41.
Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clinical Infectious Diseases, (2004); 38(8): 1049-1055.
Woodford N, Adebiyi A-MA, Palepou M-FI, Cookson BD. Diversity of VanA glycopeptide resistance elements in Enterococci from humans and nonhuman sources. Antimicrobial Agents and Chemotherapy, (1998); 42(3): 502-508.
Daum RS, Gupta S, Sabbagh R, Milewski WM. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. Journal of Infectious Diseases, (1992); 166(5): 1066-1072.
Billot-Klein D, Gutmann L, Bryant D, Bell D, Van Heijenoort J, et al. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. Journal of Bacteriology, (1996); 178(15): 4696-4703.
Finks J, Wells E, Dyke TL, Husain N, Plizga L, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerging Infectious Diseases, (2009); 15(6): 943-945.
Refbacks
- There are currently no refbacks.